Top Markets
#1 MowCat MowCat +49.01%
#2 Derive Derive +24.21%
#3 Audiera Audiera +19.54%
#4 Geodnet Geodnet +16.54%
#5 aPriori aPriori +15.50%
#6 Biconomy Biconomy +14.76%
#7 Cross Cross +14.26%
#8 Humanity Humanity +12.39%
#9 Quack AI Quack AI +11.55%
#10 Palladium Network Palladium Network +10.79%
Coin of the day
MowCat MowCat
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Rhinomed Limited Rhinomed Limited

Rhinomed Limited

RNO
Rang in Aktien #35584
Headquartered in Cremorne, Australia, Rhinomed Limited is a global enterprise... Headquartered in Cremorne, Australia, Rhinomed Limited is a global enterprise dedicated to the research, development, and market introduction of consumer and medical devices. Since its incorporation in 2004, the company has focused on creating wearable nasal technologies designed to optimize breathing, improve sleep quality, support general health, and assist in disease diagnosis. Its product offerings include the Turbine, which enhances athletic breathing; Mute, aimed at reducing snoring and promoting clearer airflow; Pronto, a vapor inhaler developed to aid airflow and sleep; and Rhinoswab, utilized for efficient nasal sample collection. Beyond these products, Rhinomed is actively engaged in developing programs across diverse fields such as sleep architecture, the cognitive impact of sleep and respiratory function, obstructive sleep apnea, pain and nausea relief, respiratory diseases, and advanced diagnostics and sensors. The company also provides a distinct drug delivery platform specifically for cannabinoid formulations. Formerly known as Consegna Group Limited, the company adopted the name Rhinomed Limited in November 2013.
Aktienkurs
$0.0260778
Zuletzt synchronisiert: 2024-02-16
Marktkapitalisierung
$3.69M
Veränderung (1 Tag)
-0.09%
Veränderung (1 Jahr)
0.00%
Land
AU
Handel Rhinomed Limited (RNO)

Kategorie

Healthcare
Dividendenhistorie für Rhinomed Limited (RNO)
Rhinomed Limited (Aktienkürzel: RNO) zahlte insgesamt 0 Dividenden.
Die Summe aller Dividenden (angepasst an Aktiensplits) beträgt: 0.00
Dividendenrendite (TTM): 0
Dividendenzahlungen für Rhinomed Limited (RNO) von 2026 bis 2026
Jährliche Dividendenzahlungen
Jahr Dividende (angepasst an Aktiensplits) ändert
Nicht genügend Daten für die angegebenen Daten.
Liste aller Dividendenzahlungen
Jahr Dividende ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenzahlungen ähnlicher Unternehmen oder Wettbewerber
Unternehmen Anzahl der Dividendenzahlungen Land
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
173.00%
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
85.00%
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
178.00%
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
0.00%
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
0.00%
US